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Prior Ultrasound-Indicated Cerclage
Comparison of Cervical Length Screening or History-Indicated
Cerclage in the Next Pregnancy
Anju Suhag, MD, Jordana Reina, MD, Laura Sanapo, MD, Pasquale Martinelli, MD, Gabriele Saccone, MD,
Giuliana Simonazzi, MD, Maria Giraldo-Isaza, MD, Sushma Potti, MD, Matthew K. Hoffman, MD, MPH,
and Vincenzo Berghella, MD
OBJECTIVE: To evaluate outcomes of women with prior
ultrasound-indicated cerclage, who in their subsequent
pregnancy were either followed by transvaginal ultra-
sound cervical length screening or received a planned
history-indicated cerclage.
METHODS: Multicenter cohort study of singleton ges-
tations with a prior ultrasound-indicated cerclage per-
formed from 1994 to 2014. We evaluated three
pregnancies in the study participants: first pregnancy
with prior spontaneous preterm birth at less than 37
weeks of gestation; second pregnancy with ultrasound-
indicated cerclage for cervical length 25 mm or less; and
the third index pregnancy managed with either trans-
vaginal ultrasound cervical length screening with
ultrasound-indicated cerclage for cervical length 25 mm
or less or planned history-indicated cerclage. The pri-
mary outcome was incidence of spontaneous preterm
birth at less than 37 weeks of gestation. We planned
a subgroup analysis for women who delivered at less
than 32 weeks of gestation compared with 32 weeks of
gestation or greater in their prior ultrasound-indicated
cerclage pregnancy.
RESULTS: Of 102 singleton gestations included, 38
(37.3%) were followed with transvaginal ultrasound
cervical length screening and 64 (62.7%) underwent
history-indicated cerclage. Of 38 women in the trans-
vaginal ultrasound group, 18 (47.4%) underwent
ultrasound-indicated cerclage for cervical length 25 mm
or less. After adjusting for confounders, the rate of
spontaneous preterm birth at less than 37 weeks of
gestation was similar between transvaginal ultrasound
cervical length screening and history-indicated cerclage
groups (36.8% compared with 43.8%; adjusted odds ratio
0.77, 95% confidence interval 0.47–1.45). Secondary out-
comes were also similar in both groups. All women (n57)
who delivered at less than 32 weeks of gestation in their
prior pregnancy and subsequently had transvaginal ultra-
sound screening received ultrasound-indicated cerclage
in the index pregnancy compared with only 35.5% of
women who delivered at 32 weeks of gestation or
greater in their prior pregnancy.
CONCLUSION: Women with prior ultrasound-indicated
cerclage have similar outcomes if they receive either
transvaginal ultrasound cervical length screening with
ultrasound-indicated cerclage for cervical length 25 mm
or less or planned history-indicated cerclage in the
subsequent pregnancy. Less than 50% of the transvaginal
ultrasound cervical length screening group require
a repeat ultrasound-indicated cerclage in the subsequent
pregnancy.
(Obstet Gynecol 2015;126:962–8)
DOI: 10.1097/AOG.0000000000001086
LEVEL OF EVIDENCE: II
P reterm birth is a leading cause of perinatal mor-bidity and mortality.1 Cervical cerclage is an
obstetric procedure performed to prevent spontane-
ous preterm birth.2 Currently cerclage is placed in
singleton gestations for three indications3–6: history-
indicated—multiple prior early spontaneous preterm
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births or second-trimester losses7; ultrasound-indicated—
cervical length 25 mm or less in women with prior
spontaneous preterm birth4; and physical examination-
indicated—cervical dilation on physical examination
before 24 weeks of gestation.8–10
Women with prior spontaneous preterm birth are
usually managed in the subsequent pregnancy with
serial cervical length screening approximately every 2
weeks between 16 and 24 weeks of gestation.11–13
Approximately 42% of these women develop short
cervix (25 mm or less) before 24 weeks of gestation,
and an ultrasound-indicated cerclage is placed for pre-
maturity prevention.4 These women with prior
ultrasound-indicated cerclage are at high risk for
recurrent spontaneous preterm birth, and their man-
agement in the subsequent pregnancy is controversial.
The aim of this study was to evaluate manage-
ment in the subsequent pregnancy for women with
a prior ultrasound-indicated cerclage.
MATERIALS AND METHODS
This was a retrospective, multicenter cohort study of
singleton gestations with a prior ultrasound-indicated
cerclage from 1994 to 2014. Five tertiary referral
centers were involved: Thomas Jefferson University
Hospitals (Philadelphia, Pennsylvania), Albert Ein-
stein Medical Center (Philadelphia, Pennsylvania),
Christiana Care Health Services (Newark, Delaware),
University of Naples Federico II (Naples, Italy), and
the University of Bologna (Bologna, Italy). The
institutional review board at each institution approved
the study.
Women with a prior ultrasound-indicated cerc-
lage who had a subsequent pregnancy were included
in the analysis. We evaluated three pregnancies in
the study participants. Our study participants had
spontaneous preterm birth at less than 37 weeks of
gestation in their first evaluated pregnancy (present-
ing as preterm labor or preterm premature rupture of
membranes). The study participants then had an
ultrasound-indicated cerclage placed in the second
pregnancy for a short cervix 25 mm or less. These
women were then followed in their third pregnancy,
which was managed either by transvaginal ultra-
sound cervical length screening with ultrasound-
indicated cerclage placement only if the cervical
length shortened to 25 mm or less before 24 weeks
of gestation or planned history-indicated cerclage.
We compared the management and outcomes of
women with prior ultrasound-indicated cerclage in
the subsequent pregnancy (transvaginal ultrasound
cervical length screening or history-indicated cerc-
lage). We excluded women with cerclage placed for
a short cervix in their first pregnancy or cerclage
placed only for other risk factors of spontaneous
preterm birth (such as cone biopsy, prior multiple
loop electrosurgical excision procedure, dilation and
curettages), and women with a prior ultrasound-
indicated cerclage who had no subsequent preg-
nancy. We also excluded women who had an unclear
indication for cerclage placement. Additionally we
excluded multiple gestations, fetal anomalies, or if no
data were available for indication of a prior
ultrasound-indicated cerclage, or all of these.
Patients who underwent cerclage placement were
identified using the existing database at Thomas
Jefferson University Hospitals and a billing code
system at Albert Einstein Medical Center. Cerclage
patients at Christiana Care Health Services were
identified from an institution data warehouse and also
using surgical billing code system. The data were
collected at the University of Naples and University of
Bologna using surgical billing codes. We reviewed
maternal medical records of at least three pregnancies
in all women with a prior ultrasound-indicated
cerclage. Maternal characteristics, preterm birth risk
factors, cerclage indication and operative details, and
perinatal outcomes data were collected for all three
pregnancies in the study participants. The indication
for ultrasound-indicated cerclage placement included
a short cervix 25 mm or less (and rarely just for
funneling greater than 25% before 2005) in women
with prior spontaneous preterm birth or multiple
second-trimester losses. Data from all study sites was
reviewed by two authors (A.S., G.S.), and accuracy of
data was verified against outpatient and hospital
records (A.S. verified data from the U.S. study sites
Fig. 1. Study algorithm.
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and G.S. verified the data from Italian study sites).
The deidentified data from all five institutions were
combined in a single database before analysis.
At Thomas Jefferson University Hospitals, the
University of Naples, and the University of Bologna,
cervical cerclages were performed using the McDonald
technique with one stitch of Mersilene 5-mm tape
placed in a pursestring fashion. At Albert Einstein
Medical Center, the McDonald technique was per-
formed using a nonabsorbable braided polyester
suture. At Christiana Care Health Services, cervical
cerclage was performed using the McDonald technique
using 2-Ethibond suture. At all five institutions, the
indications for cerclage placement were similar. Intra-
operative ultrasound guidance, antibiotics, or tocolytics
were not used for the cerclage procedures. Starting at
the end of 2003, 17-hydroxyprogesterone caproate
weekly from 16 to 36 weeks of gestation was offered
to women with prior spontaneous preterm birth at all
five institutions.14 The cerclage was removed at 36–37
weeks of gestation or earlier for preterm labor, preterm
premature rupture of membranes, or if delivery was
indicated at all study sites.
The primary outcome was incidence of sponta-
neous preterm birth at less than 37 weeks of gestation.
Secondary outcomes included spontaneous preterm
birth at less than 35, less than 32, less than 28, or less
than 24 weeks of gestation; incidence of preterm
premature rupture of membranes; birth weight; and
low birth weight less than 2,500 g. Additionally, we
assessed the incidence, gestational age, and outcomes
of repeat ultrasound-indicated cerclage in the index
pregnancy. We planned a subgroup analysis of the
study participants from the United States to assess the
generalizability to the U.S. population. We also
compared the outcomes in two groups (transvaginal
ultrasound cervical length screening, history-indicated
cerclage) in women with gestational age at delivery
less than 32 and 32 weeks of gestation or greater in
prior pregnancy with ultrasound-indicated cerclage.
Sample size calculation was performed based on
results from previous studies, which showed an overall
Table 1. Maternal Demographic Characteristics in the Index Pregnancy
Characteristic
Transvaginal Ultrasound Cervical
Length Screening (Experimental
Group) (n538, 37.3%)
History-Indicated
Cerclage (Control Group)
(n564, 62.7%) P
Age (y) 29.664.2 29.765.0 .877
Race .838
African American 22 (57.9) 35 (54.7)
Other 16 (42.1) 29 (45.3)
Smoking 10 (26.3) 6 (9.5) .046
Cone biopsy 5 (13.5) 9 (14.5) .974
17-hydroxy progesterone caproate 22 (57.9) 35 (54.7) .838
Before 2005 0/6 (0) 0/11 (0) .999
During or after 2005 22/32 (68.8) 35/53 (66.0) .721
BMI (kg/m2)
Mean 33.668.3 30.968.4 .174
Greater than 30 22 (57.9) 26 (40.6) .104
Less than 19 0 3 (4.7) .292
Gravidity 4.762.4 4.661.7 .930
No. of prior spontaneous preterm births
(20 0/7–36 6/7 wk)
1.3 (1–3) 1.7 (1–3) .035
No. of prior 2nd-trimester losses (14 0/7–19
6/7 wk)
0.6 (0–3) 0.8 (0–3) .774
Earliest gestational age at prior spontaneous
preterm birth (20 0/7–36 6/7 wk)
29.165.5 26.564.9 .087
Earliest gestational age at prior 2nd-trimester
loss (14 0/7–19 6/7 wk)
16.461.1 17.161.1 .178
Prior ultrasound-indicated cerclage placement
Gestational age (wk) 19.562.1 19.362.5 .832
Cervical length (mm) 17.665.8 17.566.6 .947
Prior ultrasound-indicated cerclage delivery
Gestational age (wk) 34.067.0 31.367.2 .064
Delivery at less than 32 wk of gestation 11 (29.9) 30 (46.9) .057
BMI, body mass index.
Data are mean6standard deviation, n (%), n/N (%), or median (range), unless otherwise specified.
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incidence of preterm birth at less than 37 weeks of
gestation of 26% in women who underwent history-
indicated cerclage7 and 42% among women who
underwent ultrasound-indicated cerclage.4 For 80%
power and a two-sided a of 0.05, 138 women in the
experimental group and 138 women in the control
group are required.
Statistical analysis was performed using SPSS
19.0. Data were shown as means6standard deviation
or as number (%). Categorical variables were com-
pared using the x2 or Fisher’s exact test. Within-
group comparison was undertaken using Wilcoxon
and Mann-Whitney tests. P,.05 was considered sta-
tistically significant. Multivariate logistic regression
was performed to correct data for those variables sig-
nificantly different between groups. Survival curves
for gestational age at delivery were obtained by
Kaplan-Meier estimated and compared by Cox
regression. The study was performed following the
Strengthening The Reporting of OBservational stud-
ies in Epidemiology guidelines.15
RESULTS
We reviewed a total of 1,709 charts at the study sites.
Of these 1,709, we identified 157 women who had
a subsequent pregnancy after a prior ultrasound-
indicated cerclage. After review of medical records,
55 women were excluded and remaining the 102
singleton gestations with a prior ultrasound-indicated
cerclage were included in the study (Fig. 1). Of these
102 women with prior ultrasound-indicated cerclage,
in the next pregnancy, 38 (37.3%) had transvaginal
ultrasound cervical length screening, whereas 64
(62.7%) women underwent planned history-indicated
cerclage. Of the 38 women who were managed with
transvaginal ultrasound cervical length screening, 18
(47.4%) women underwent ultrasound-indicated cerc-
lage for cervical length 25 mm or less.
Demographic characteristics were similar in the
transvaginal ultrasound cervical length screening
and history-indicated cerclage groups, except for
a significantly higher rate of smoking in the trans-
vaginal ultrasound cervical length screening group
(P5.04) and higher number of prior spontaneous
preterm birth in the history-indicated cerclage
group (P5.03) (Table 1).
After adjusting for confounders (smoking, number
and earliest gestational age of prior spontaneous pre-
term birth[s], and gestational age at delivery in prior
pregnancies), the primary outcome, the rate of sponta-
neous preterm birth at less than 37 weeks of gestation,
was similar between transvaginal ultrasound cervical
length screening and history-indicated cerclage (36.8%
compared with 43.8%; adjusted odds ratio 0.77, 95%
confidence interval 0.47–1.45; Table 2). A similar pat-
tern was noted for each of the secondary outcomes
(Table 2). Approximately 39% of women with
ultrasound-indicated cerclage in the index pregnancy
Table 2. Primary and Secondary Outcomes in the Index Pregnancy
Outcome
Transvaginal
Ultrasound
Cervical Length
Screening
(Experimental Group)
(n538, 37.3%)
History-Indicated
Cerclage
(Control Group)
(n564, 62.7%) OR (95% CI)
Adjusted OR
(95% CI)
Gestational age at
delivery (wk)
35.765.5 34.266.9 Mean difference 21.5 wk
(95% CI 23.96 to 0.96)
NA
Spontaneous preterm birth
(wk of gestation)
Less than 37 14 (36.8) 28 (43.8) 0.87 (0.21–2.58) 0.77 (0.47–1.45)
Less than 35 6 (15.8) 18 (28.1) 0.74 (0.27–2.63) 0.71 (0.33–2.45)
Less than 32 6 (15.8) 14 (21.9) 0.84 (0.49–2.59) 0.84 (0.52–2.33)
Less than 28 5 (13.2) 13 (20.3) 0.77 (0.17–33.64) 0.63 (0.13–7.87)
Less than 24 3 (7.9) 8 (12.5) 1.86 (0.02–3.72) 1.11 (0.42–6.54)
Preterm PROM 6 (15.8) 8 (12.5) 1.11 (0.94–3.12) 1.07 (0.88–3.02)
Birth weight (g) 2,7896852 2,69361,019 Mean difference 296.00 g
(95% CI 2464.39 to
272.39)
NA
Low birth weight* 8 (21.1) 15 (23.4) 0.94 (0.73–1.17) 0.81 (0.31–2.03)
OR, odds ratio; CI, confidence interval; NA, not applicable; PROM, premature rupture of membranes.
Data are mean6standard deviation or n (%)unless otherwise specified.
* Birth weight less than 2,500 g.
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delivered before 37 weeks of gestation and had a lower
mean gestational age at delivery (33.866.9 weeks of
gestation). Kaplan-Meier survival curve for gestational
age at delivery showed no statistically significant ben-
efit in transvaginal ultrasound cervical length screening
compared with history-indicated cerclage management
(P5.26) (Fig. 2).
Additionally, we performed a subgroup analysis
of primary and secondary outcomes in women who
delivered at less than 32 weeks and 32 weeks of
gestation or greater with their prior ultrasound-
indicated cerclage pregnancy in the two study
groups (transvaginal ultrasound cervical length
screening, history-indicated cerclage). The outcomes
were noted to be similar in two study groups in
women with a prior ultrasound-indicated cerclage
who delivered at less than 32 weeks of gestation in
their prior pregnancy and in women who delivered
at 32 weeks of gestation or greater in a prior
pregnancy with ultrasound-indicated cerclage.
Overall we noted a higher rate of spontaneous
preterm birth at less than 37 weeks of gestation
and lower gestational age at delivery in women who
delivered at less than 32 weeks of gestation com-
pared with those who delivered at 32 weeks of
gestation or greater in a prior pregnancy with
ultrasound-indicated cerclage (Table 3). All women
(n57) who delivered at less than 32 weeks of gesta-
tion in their prior pregnancy and subsequently
had transvaginal ultrasound screening received
ultrasound-indicated cerclage in the index pregnancy,
compared with only 35.5% of women who delivered
at 32 weeks of gestation or greater in their prior preg-
nancy (Table 3).
We also performed a subanalysis of study partic-
ipants from the U.S. study sites (Thomas Jefferson
University Hospitals, Albert Einstein Medical Center,
Christiana Care Health Services). Results were similar
to the overall analysis (Appendices 1–3, available on-
line at http://links.lww.com/AOG/A701).
DISCUSSION
This multicenter retrospective study showed that
women with prior ultrasound-indicated cerclage have
similar outcomes if they receive in the subsequent
pregnancy either transvaginal ultrasound cervical
length screening with ultrasound-indicated cerclage
for cervical length 25 mm or less or a planned history-
indicated cerclage. Less than 50% of the women in the
transvaginal ultrasound cervical length screening
group required a repeat ultrasound-indicated cerclage
in the subsequent pregnancy. The outcomes were
noted overall to be similar in two subgroups of
women with prior ultrasound-indicated cerclage who
delivered either at less than 32 weeks or 32 weeks of
gestation or greater in the prior pregnancy with
ultrasound-indicated cerclage.
The old myth of “once a cerclage, always a cerc-
lage in subsequent pregnancy” has been proven
wrong by available evidence.3,16–18 Fejgin et al18 in
1994 suggested that in patients with a history of prior
cerclage for nontraditional indications, a repeat
history-indicated cerclage may not be indicated and
may in fact be deleterious to the woman and the preg-
nancy. Pelham et al16 also noted that the outcomes
and rate of preterm birth in women with a prior
cerclage (history-indicated cerclage or ultrasound-
indicated cerclage) for untraditional (unclear or inap-
propriate) indications other than cervical insufficiency
are noted to be similar in transvaginal ultrasound
screening and history-indicated cerclage in the subse-
quent pregnancy. Limited literature of prior cerclage
(combined history-indicated cerclage and ultrasound-
indicated cerclage) showed no benefit of repeat cerc-
lage in subsequent pregnancy.16 Our study results
suggest that women with a prior ultrasound-
indicated cerclage could be safely managed with trans-
vaginal ultrasound cervical length screening and help
Fig. 2. Kaplan-Meier curves for pregnancy maintenance in
women who were followed with transvaginal ultrasound
cervical length screening and those who underwent history-
indicated cerclage. P5.26 (Cox regression).
Suhag. Management of Women With Prior Ultrasound-Indicated
Cerclage. Obstet Gynecol 2015.
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avoid cerclage in approximately 50% of women, in
whom cervical length remains greater than 25 mm
in the subsequent pregnancy. Our study data support
the previously published meta-analysis that only 42%
women developed a short cervix and received
ultrasound-indicated cerclage in transvaginal ultra-
sound cervical length screening in women with prior
preterm birth with a short cervix.5 Moreover, our re-
sults concur with a very recent European study.19 In
this small cohort study, also including women who
underwent planned abdominal cerclage, women with
a prior ultrasound-indicated cerclage who received
history-indicated cerclage had a similar outcome com-
pared with those who underwent cervical surveillance
in the next pregnancy.19
One of the strengths of our study is the inclusion
of a specific population, that is, singleton gestations
with a prior ultrasound-indicated cerclage. This is the
first study evaluating this clinical dilemma specifically
between planned history-indicated cerclage compared
with transvaginal ultrasound cervical length screening
with ultrasound-indicated cerclage as indicated. No
similar publications were found by a systematic
review: searches were performed in MEDLINE,
Scopus, Sciencedirect.com, ClinicalTrials.gov, and
EMBASE with the use of the following keywords:
“cerclage,” “cervical cerclage,” “ultrasound indicated
cerclage,” “history indicated cerclage,” and “preterm
birth from beginning of each database to May 2015”
Primary and secondary outcomes were established as
a priori. As a result of the multicenter and multina-
tional nature of our study, we performed a subanalysis
of women from the U.S. sites only, and the outcomes
in study subjects from the United States were noted to
be similar comparing all study participants. Our study
data support that ultrasound-indicated cerclage is
beneficial for a subset of women who undergo trans-
vaginal ultrasound cervical length screening, and
history-indicated cerclage should not be offered as
the one and only option to these women.
Table 3. Subgroup Analysis of Outcomes of Women With Prior Preterm Birth at Less Than 32 Weeks of
Gestation or 32 Weeks of Gestation or Greater in Women With Prior Ultrasound-Indicated
Cerclage
Outcome
Spontaneous Preterm Birth at Less Than 32 Wk of
Gestation in the Pregnancy With Prior
Ultrasound-Indicated Cerclage
(n534, 33.3%)
Spontaneous Preterm Birth at 32 Wk of
Gestation or Greater in the Pregnancy With
Prior Ultrasound-Indicated Cerclage
(n568, 66.7%)
Transvaginal
Ultrasound
Cervical Length
Screening
(Experimental
Group) (n57,
20.6%)
History-
Indicated
Cerclage
(Control
Group)
(n527,
79.4%)
Adjusted OR
(95% CI)
Transvaginal
Ultrasound
Cervical Length
Screening
(Experimental
Group) (n531,
45.6%)
History-
Indicated
Cerclage
(Control
Group)
(n537,
54.4%)
Adjusted OR
(95% CI)
Gestational age at
delivery (wk)
29.968.7 30.468.2 P5.888 36.963.7 36.864.4 P5.873
Spontaneous preterm
birth (wk of
gestation)
Less than 37 4 (57.1) 16 (59.3) 0.97 (0.47–1.97) 8 (25.8) 11 (29.7) 0.87 (0.40–1.89)
Less than 35 4 (57.1) 14 (51.9) 1.10 (0.53–2.30) 2 (6.5) 3 (8.1) 0.80 (0.14–4.46)
Less than 32 4 (57.1) 12 (44.4) 1.29 (0.60–2.77) 2 (6.5) 2 (5.4) 1.19 (0.18–7.99)
Less than 28 3 (42.9) 11 (40.7) 1.40 (0.64–3.08) 2 (6.5) 2 (5.4) 1.19 (0.18–7.99)
Less than 24 2 (28.6) 6 (22.2) 1.29 (0.33–5.05) 1 (3.2) 1 (2.7) 1.19 (0.08–18.31)
Preterm PROM 3 (42.9) 7 (25.9) 1.65 (0.57–4.80) 3 (9.7) 1 (2.7) 3.58 (0.39–32.71)
Birth weight (g) 1,95761,364 2,17261,285 P5.738 2,9566619 3,0356607 P5.607
Low birth weight* 3 (42.9) 9 (33.3) 1.57 (0.54–2.74) 1 (3.2) 1 (2.7) 1.19 (0.08–18.31)
Incidence of
ultrasound-
indicated
cerclage
7 (100) NA NA 11 (35.5) NA NA
OR, odds ratio; CI, confidence interval; PROM, premature rupture of membranes; NA, not applicable.
Data are mean6standard deviation or n (%)unless otherwise specified.
* Birth weight less than 2,500 g.
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There are two important limitations of our study.
First, it is a retrospective, nonrandomized comparison
of patients accrued over 20 years at five centers.
Therefore, the potential for treatment as well as
ascertainment bias is great. Second, our study is
markedly underpowered, because we accrued less
than half of our necessary sample size. This lack of
power is only intensified in the subgroup analyses. An
additional limitation is that we were unable to obtain
neonatal data including prematurity complications
such as respiratory distress syndrome, intraventricular
hemorrhage, necrotizing enterocolitis, neonatal sepsis,
and neonatal death.
In summary, in this retrospective study, women
with prior ultrasound-indicated cerclage had similar
outcomes whether they received either transvaginal
ultrasound cervical length screening with ultrasound-
indicated cerclage for cervical length 25 mm or less or
planned history-indicated cerclage in the subsequent
pregnancy.
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